CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Prologue Medicines Appoints Stephen Harrison, Ph.D., as Chief Scientific Officer

Positive
AI Analysis

Summary

Prologue Medicines appointed Stephen Harrison, Ph.D., as Chief Scientific Officer and welcomed Jason Silvers and Adrian Rawcliffe to its Board of Directors.

Importance:2/10
Sentiment:
0.30
managementboard_appointmentCSO_appointment

Read the original article

Published by PR Newswire Biotech on October 13, 2026 2:00 PM

Read Original